| Trial ID: | L0096 |
| Source ID: | NCT02329405
|
| Associated Drug: |
Rifampicin
|
| Title: |
The Effects of PXR Activation on Hepatic Fat Content
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Rifampicin|Drug: Placebo
|
| Outcome Measures: |
Hepatic fat fraction
|
| Sponsor/Collaborators: |
University of Oulu|Oulu University Hospital
|
| Gender: |
All
|
| Age: |
18 Years to 40 Years ?? (Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
16
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science
|
| Start Date: |
December 2014
|
| Completion Date: |
January 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
November 1, 2017
|
| Locations: |
Oulu University Hospital, Oulu, Finland
|
| URL: |
https://ClinicalTrials.gov/show/NCT02329405
|
